AVAYL

AVAYL offers a software optimisation tool for pharmaceutical and life science product portfolio management. AVAYL aims to replace traditional manual analysis with dynamic intelligence, enabling quicker, data-driven actions in the $18 billion pharmaceutical intelligence sector.

AVAYL is a company in artificial intelligence.

Its activity falls under artificial intelligence; the profile below is assembled from public directory data.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: avayl.tech